112 related articles for article (PubMed ID: 6406670)
1. Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsin.
Rich DH; Salituro FG
J Med Chem; 1983 Jun; 26(6):904-10. PubMed ID: 6406670
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
Rich DH; Sun ET; Ulm E
J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effect of structure in subsite P3 on inhibition of pepsin.
Rich DH; Bernatowicz MS
J Med Chem; 1982 Jul; 25(7):791-5. PubMed ID: 6809942
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of dideoxy-pepstatin. Mechanism of inhibition of porcine pepsin.
Rich DH; Sun E; Singh J
Biochem Biophys Res Commun; 1977 Jan; 74(2):762-7. PubMed ID: 319803
[No Abstract] [Full Text] [Related]
5. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
Maibaum J; Rich DH
J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
[TBL] [Abstract][Full Text] [Related]
6. Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.
Holladay MW; Salituro FG; Rich DH
J Med Chem; 1987 Feb; 30(2):374-83. PubMed ID: 3100803
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of new conformationally restricted analogues of pepstatin.
Szewczuk Z; Rebholz KL; Rich DH
Int J Pept Protein Res; 1992; 40(3-4):233-42. PubMed ID: 1478780
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.
Rich DH; Bernatowicz MS; Agarwal NS; Kawai M; Salituro FG; Schmidt PG
Biochemistry; 1985 Jun; 24(13):3165-73. PubMed ID: 3927973
[TBL] [Abstract][Full Text] [Related]
9. Pepstatin-insenstive acid proteases from Scytalidium lignicolum. Kinetic study with synthetic peptides.
Morihara K; Tsuzuki H; Murao S; Oda K
J Biochem; 1979 Mar; 85(3):661-8. PubMed ID: 34596
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin.
Agarwal NS; Rich DH
J Med Chem; 1986 Dec; 29(12):2519-24. PubMed ID: 3783611
[TBL] [Abstract][Full Text] [Related]
11. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
12. Solid-phase synthesis of a soluble pepstatin derivative suitable for therapeutic use.
Austen BM; Ford TF; Grant DA; Hermon-Taylor J
Biosci Rep; 1982 Jun; 2(6):427-32. PubMed ID: 6809068
[No Abstract] [Full Text] [Related]
13. New pepstatin analogues: synthesis and pepsin inhibition.
McConnell RM; Frizzell D; Camp A; Evans A; Jones W; Cagle C
J Med Chem; 1991 Jul; 34(7):2298-300. PubMed ID: 2067002
[No Abstract] [Full Text] [Related]
14. Mechanism of inhibition of pepsin by pepstatin. Effect of inhibitor structure on dissociation constant and time-dependent inhibition.
Rich DH; Sun ET
Biochem Pharmacol; 1980 Aug; 29(16):2205-12. PubMed ID: 6775634
[No Abstract] [Full Text] [Related]
15. Synthesis of novel semi-synthetic tight binding inhibitors of pepsin.
Huddy SP; Patel G; Heywood GC; Austen BM; Hermon-Taylor J
Biochem Soc Trans; 1989 Dec; 17(6):1124-5. PubMed ID: 2516823
[No Abstract] [Full Text] [Related]
16. Pepsin inhibition by a high specific activity radioiodinated derivative of pepstatin.
Workman RJ; Burkitt DW
Arch Biochem Biophys; 1979 Apr; 194(1):157-64. PubMed ID: 375833
[No Abstract] [Full Text] [Related]
17. Pepstatin inhibition mechanism.
Marciniszyn J; Hartsuck JA; Tang J
Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
[TBL] [Abstract][Full Text] [Related]
18. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.
Tözsér J; Weber IT; Gustchina A; Bláha I; Copeland TD; Louis JM; Oroszlan S
Biochemistry; 1992 May; 31(20):4793-800. PubMed ID: 1591240
[TBL] [Abstract][Full Text] [Related]
19. Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation.
Rao CM; Scarborough PE; Kay J; Batley B; Rapundalo S; Klutchko S; Taylor MD; Lunney EA; Humblet CC; Dunn BM
J Med Chem; 1993 Sep; 36(18):2614-20. PubMed ID: 8410973
[TBL] [Abstract][Full Text] [Related]
20. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
Wang W; Liang TC
Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]